[Federal Register Volume 75, Number 197 (Wednesday, October 13, 2010)]
[Notices]
[Page 62857]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-25773]



[[Page 62857]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

National Drug Intelligence Center

[OMB Number 1105-0087]


Agency Information Collection Activities: Proposed Extension With 
Change of a Previously Approved Collection; Comments Requested:

ACTION: 30-Day Notice of Information Collection Under Review: Extension 
with Change of a Previously Approved Collection SENTRY Synthetic Drug 
Early Warning and Response System.

-----------------------------------------------------------------------

     The United States Department of Justice (DOJ), National Drug 
Intelligence Center (NDIC), will be submitting the following 
information collection request to the Office of Management of Budget 
(OMB) for review and approval in accordance with the Paperwork 
Reduction Act of 1995. The proposed information collection is published 
to obtain comments from the public and affected agencies. This proposed 
information collection was previously published in the Federal Register 
Volume 75, Number 1571, pages 49946-49947 on August 16, 2010, allowing 
for a 60 day comment period.
    The purpose of this notice is to allow for an additional 30 days 
for public comment until November 12, 2010. This process is conducted 
in accordance with 5 CFR 1320.10.
    Written comments and/or suggestions regarding the items contained 
in this notice, especially the estimated burden and associated response 
time, should be directed to the Office of Management and Budget, Office 
of Information and Regulatory Affairs, Attention Department of Justice 
Desk Officer, Washington, DC 20503. Additionally, comments may be 
submitted to OMB via facsimile to (202) 395-5806. Written comments and 
suggestions from the public and affected agencies concerning the 
proposed collection of information are encouraged. Your comments should 
address one or more of the following four points:
    <bullet> Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    <bullet> Evaluate the accuracy of the agency's estimate of the 
burden of the proposed collection of information, including the 
validity of the methodology and assumptions used;
    <bullet> Enhance the quality, utility, and clarity of the 
information to be collected; and
    <bullet> Minimize the burden of the collection of information on 
those who are to respond, including through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses.

Overview of This Information Collection

    (1) Type of Information Collection: Extension with Change of a 
Previously Approved Collection.
    (2) Title of the Form/Collection: SENTRY Synthetic Drug Early 
Warning and Response System.
    (3) Agency form number, if any, and the applicable component of the 
Department sponsoring the collection: Form Number: NDIC Form <greek-i> 
N/A.
    (4) The 2004 National Synthetic Drugs Action Plan designated the 
NDIC as the lead agency for developing an early warning and response 
system. This instrument is critical for NDIC to detect emerging drug 
abuse and production trends and thereafter notify law enforcement 
demand authorities and prepare associated reports.
    From February 2009 until September 2010, the SENTRY Synthetic Drug 
Early Warning and Response System was available only to specifically 
targeted groups including chemists; education providers (teachers, 
administrators, school resource officers, or school nurses); law 
enforcement personnel; treatment providers (physicians, nurses, 
emergency medical technicians, medical examiners); and other specific 
groups such as drug intelligence analysts.
    The NDIC has determined that some SENTRY information may be of 
interest to members of the general public. As of June 2010, all SENTRY 
DrugAlert Watches, Drug Alert Warnings, and News and Bulletins have 
been made accessible to this group via the NDIC public facing Web site. 
The NDIC will make a SENTRY Geographic Information System map 
accessible to the public that includes color-coded substance 
categories, submission/event details, and a general locality of each 
submission/event.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: It is estimated 
that approximately annually 300 respondents will tender a submission/
event requiring approximately 15 minutes. Use of the system is expected 
to increase significantly.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: There is an estimated 75 total annual burden hours 
associated with this collection.
    If you have comments especially on the estimated public burden or 
associated response time, suggestions, or need a copy of the proposed 
information collection instrument with instructions or additional 
information, please contact Kevin M. Walker, General Counsel, National 
Drug Intelligence Center, Fifth Floor, 319 Washington Street, 
Johnstown, PA 15901.
    If additional information is required contact: Mrs. Lynn Murray, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, 145 N Street, 
NE., 2E-502, Washington, DC 20530.

    Dated: October 7, 2010.
Lynn Murray,
Department Clearance Officer, PRA, U.S. Department of Justice.
[FR Doc. 2010-25773 Filed 10-12-10; 8:45 am]
BILLING CODE 4410-DC-P